Hansen Medical (HNSN) 1.05 $HNSN
Global Medical Robotics Market Outlook 2015-2018
M2 - Wed Feb 11, 9:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz7pq9/global_medical) has announced the addition of the "Global Medical Robotics Market Outlook 2018" report to their offering. Robot-assisted radical prostatectomy is becoming the standard of care in urology, accounting for about 85% of all prostate operations in the United States. According to Intuitive Surgical, hysterectomy and other procedures, such as gallbladder removal and kidney surgery, are also driving the growth in robotic operations. According to our report, the Global Medical Robotics Market Outlook 2018, is currently worth US$ 3.2 Billion and will grow up to US$ 6.4 Billion by 2018. The report provides an overview of the total robotics market and its two main segments, which comprise Industrial Robots and Service Robots. This is followed by the present role of robotics in the healthcare industry along with the various pros and cons of integration of robotics. Segmentation of the market has been performed on the basis of the application areas as well as geographic location. The report talks about three major application areas that include Surgery, Rehabilitation, and Hospital & Laboratory. On the basis of geographic location, the market has been segmented into the US, Europe, Asia-Pacific, and the Rest of the World. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Robotics - Market Overview 4. Robotics in Healthcare 6. Drivers 7. Challenges 8. Competitive Landscape 9. Future Outlook Companies Mentioned - Accuray - Hansen Medical - Intuitive Surgical - iRobot - Stryker Corporation - Renishaw - Mazor Robotics - Stereotaxis For more information visit http://www.researchandmarkets.com/research/lz...al_medical
ISRG: 510.73 (+3.02), HNSN: 1.05 (+0.02), MZOR: 11.79 (+0.16), SYK: 94.51 (+1.14)
Hansen Medical to Highlight Magellan(TM) Robotic Embolization Procedures at 40th Annual Society of Interventional Radiology Meeting
Marketwired - Wed Feb 11, 8:02AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 40th Annual Society of Interventional Radiology (SIR) Scientific Meeting March 1 - March 4 at the Georgia World Congress Center in Atlanta, GA. The Company will showcase the Magellan 6Fr Robotic Catheter being used by Interventional Radiologists in embolization procedures, and will conduct Magellan Robotic System demonstrations at exhibit booth #1153.
HNSN: 1.05 (+0.02)
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study
Marketwired - Thu Feb 05, 8:01AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced FDA approval of an expanded protocol for the ARTISAN-AF IDE Study. The amended protocol now includes the use of the Thermocool(R) SmartTouch(R) Catheter (BioSense Webster, Diamond Bar, CA) and the EnSite Velocity Cardiac Mapping System (St. Jude Medical, St. Paul, MN). These technologies are used in conjunction with the Sensei(R) Robotic System to complete ablation procedures for the treatment of paroxysmal atrial fibrillation per the IDE study protocol.
HNSN: 1.05 (+0.02), STJ: 67.48 (+0.65)
Study Finds Magellan(TM) Robotic System From Hansen Medical Reduces Radiation to Operator by Over 80% in Transarterial Chemoembolization (TACE) Procedures
Marketwired - Tue Feb 03, 10:41PM CST
Hansen Medical, Inc. (NASDAQ: HNSN) -- An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting (February 28 - March 5, 2015, Atlanta, GA), found the use of the Magellan(TM) Robotic System in transarterial chemoembolization (TACE) procedures is feasible, and that remote robotic catheter navigation with Magellan leads to over 80% reduction in radiation dose to the operating physician when compared with a bedside control. Lead investigator Dr. Sandeep Rao, MD, MBA authored the abstract, which reviewed the results of seven patients treated with robot-assisted TACE using the Magellan 6Fr Robotic Catheter over a 5 month period at Sierra Medical Center in El Paso, Texas.
HNSN: 1.05 (+0.02)
IDEXX Tops Q4 Earnings, Lags Revenues; Tweaks 2015 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:25AM CST
IDEXX Laboratories, Inc. (IDXX), reported adjusted earnings per share (EPS) of 95 cents in the fourth quarter of 2014.
HNSN: 1.05 (+0.02), EW: 134.23 (+1.89), IDXX: 159.08 (+1.72), HOLX: 30.46 (+0.21)
Can the Rally in Hansen Medical (HNSN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 9:03AM CST
Can the Rally in Hansen Medical (HNSN) Shares Continue?
HNSN: 1.05 (+0.02)
Hansen Medical to Showcase Magellan(TM) Robotic System at 2015 International Aortic Summit (IAS)
Marketwired - Thu Jan 29, 8:02AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the International Aortic Summit (IAS) from February 11-13 at the Hyatt Regency in Palm Beach, AW. The Company will showcase its Magellan Robotic Catheters and will conduct Magellan Robotic System demonstrations at exhibit booth #11.
HNSN: 1.05 (+0.02)
Hansen up on first Magellan surgery in Australia
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 11:56AM CST
HNSN: 1.05 (+0.02)
Hansen Medical Announces Completion of First Clinical Procedure With the Magellan(TM) Robotic System in Australia
Marketwired - Tue Jan 27, 6:30PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first clinical procedure with the Magellan(TM) Robotic System in Australia. Interventional radiologists Dr. Gerard Goh and Dr. Jim Koukounaras, assisted by Professor Ken Thomson, performed the procedure at The Alfred Hospital in Melbourne, Australia. The Magellan Robotic System was installed in January 2015 in collaboration with Medtel Pty Limited, Hansen Medical's exclusive distribution partner in Australia and New Zealand.
HNSN: 1.05 (+0.02)
3 Health Care Stocks Under $10 to Watch: MannKind and More
at The Street - Tue Jan 27, 12:05PM CST
Keep an eye on these under-$10 health care stocks making big moves to the upside.
HNSN: 1.05 (+0.02), GERN: 3.03 (unch), MNKD: 7.00 (+0.02)
Hansen Medical to Showcase New Magellan(TM) 6Fr Robotic Catheter at 27th Annual ISET Meeting
Marketwired - Tue Jan 20, 4:30PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 27th Annual International Symposium on Endovascular Therapy (ISET) January 31-February 4 at the Diplomat Hotel in Hollywood, FL. The Company will showcase the new Magellan 6Fr Robotic Catheter and will conduct Magellan Robotic System demonstrations at exhibit booth #305.
HNSN: 1.05 (+0.02)
Is Myriad Genetics (MYGN) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 12:00PM CST
On Jan 14, 2015, Zacks Investment Research upgraded Myriad Genetics Inc. (MYGN) to a Zacks Rank #2 (Buy).
ABMD: 60.39 (+0.46), MYGN: 34.03 (+0.40), HNSN: 1.05 (+0.02), EW: 134.23 (+1.89)
Cyberonics (CYBX) Now a Buy: Are You Considering? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 3:35PM CST
On Jan 14, 2015, Zacks Investment Research upgraded Cyberonics Inc. (CYBX).
ABMD: 60.39 (+0.46), HNSN: 1.05 (+0.02), EW: 134.23 (+1.89), CYBX: 57.03 (+0.26)
IDEXX CAG, Global Growth Solid; Catalyst One in Focus in '15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 12:20PM CST
On Jan 7, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
HNSN: 1.05 (+0.02), EW: 134.23 (+1.89), IDXX: 159.08 (+1.72), ANGO: 18.78 (+0.18)
Global Medical Robotics Market 2014-2020: Orthopedic, Neurology, Laparoscopy - Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Wed Jan 07, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/clshb9/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. Key Topics Covered: 1. Executive Summary 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/cl...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Hot Stock: Hansen Medical, Shares Drop 5.2% (HNSN)
Comtex SmarTrend(R) - Wed Dec 24, 10:34AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing penny stocks, down 5.2% to $0.54 on 1.1x average daily volume. Thus far today, Hansen Medical has traded 383,000 shares, vs. average volume of 351,000 shares per day. The stock has underperformed the Dow (-5.2% to the Dow's 0.3%) and underperformed the S&P 500 (-5.2% to the S&P's 0.2%) during today's trading.
HNSN: 1.05 (+0.02)
Hot Stock: Hansen Medical, Shares Gain 6.6% (HNSN)
Comtex SmarTrend(R) - Fri Dec 19, 10:09AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing penny stocks, up 6.6% to $0.63 on 2.7x average daily volume. Thus far today, Hansen Medical has traded 749,000 shares, vs. average volume of 279,000 shares per day. The stock has outperformed the Dow (5.9% to the Dow's 0.2%) and outperformed the S&P 500 (5.9% to the S&P's 0.3%) during today's trading.
HNSN: 1.05 (+0.02)
Hansen Medical Announces Key Developments in Global Expansion Strategy
Marketwired - Fri Dec 19, 7:55AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced key recent developments in the company's global expansion strategy. Hansen and AB Medica s.p.a today announced an exclusive distribution agreement for Magellan(TM) and Sensei(R) Robotic Systems in Italy. In addition, the company's exclusive distribution partner in Kingdom of Saudi Arabia and United Arab Emirates, AFYA Medical Group, completed the first end user hospital installation of a Magellan system in the Middle East, at King Fahd Hospital in Jeddah, Saudi Arabia, in October.
HNSN: 1.05 (+0.02)
Global Medical Robotics Market 2014-2020: Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Fri Dec 12, 2:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/vg63ft/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. This technology, however, is limited to economies that are invested in medical care to a great extent. For instance, the possibility of investment into robotic arms to enhance surgical procedure in public hospitals in a developing country such as Ghana is unlikely but the developed economies of North America and Europe are the most lucrative markets for medical robotics as they have significantly invested in healthcare. However; Asian countries such as India and China are the markets of the future as the governments of these coutries are putting in efforts to improve healthcare and the economies will show a significant growth. Key Topics Covered: 1. Executive summery 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/vg...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Stock to Watch: Hansen Medical Down 6.5% (HNSN)
Comtex SmarTrend(R) - Thu Dec 04, 12:40PM CST
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing penny stocks, down 6.5% to $0.69 on 1.6x average daily volume. Thus far today, Hansen Medical has traded 349,000 shares, vs. average volume of 217,000 shares per day. The stock has underperformed the Dow (-6.2% to the Dow's 0.0%) and underperformed the S&P 500 (-6.2% to the S&P's 0.0%) during today's trading.
HNSN: 1.05 (+0.02)
Global Medical Robotics Market Outlook 2015-2018
M2 - Wed Feb 11, 9:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz7pq9/global_medical) has announced the addition of the "Global Medical Robotics Market Outlook 2018" report to their offering. Robot-assisted radical prostatectomy is becoming the standard of care in urology, accounting for about 85% of all prostate operations in the United States. According to Intuitive Surgical, hysterectomy and other procedures, such as gallbladder removal and kidney surgery, are also driving the growth in robotic operations. According to our report, the Global Medical Robotics Market Outlook 2018, is currently worth US$ 3.2 Billion and will grow up to US$ 6.4 Billion by 2018. The report provides an overview of the total robotics market and its two main segments, which comprise Industrial Robots and Service Robots. This is followed by the present role of robotics in the healthcare industry along with the various pros and cons of integration of robotics. Segmentation of the market has been performed on the basis of the application areas as well as geographic location. The report talks about three major application areas that include Surgery, Rehabilitation, and Hospital & Laboratory. On the basis of geographic location, the market has been segmented into the US, Europe, Asia-Pacific, and the Rest of the World. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Robotics - Market Overview 4. Robotics in Healthcare 6. Drivers 7. Challenges 8. Competitive Landscape 9. Future Outlook Companies Mentioned - Accuray - Hansen Medical - Intuitive Surgical - iRobot - Stryker Corporation - Renishaw - Mazor Robotics - Stereotaxis For more information visit http://www.researchandmarkets.com/research/lz...al_medical
ISRG: 510.73 (+3.02), HNSN: 1.05 (+0.02), MZOR: 11.79 (+0.16), SYK: 94.51 (+1.14)
Hansen Medical to Highlight Magellan(TM) Robotic Embolization Procedures at 40th Annual Society of Interventional Radiology Meeting
Marketwired - Wed Feb 11, 8:02AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 40th Annual Society of Interventional Radiology (SIR) Scientific Meeting March 1 - March 4 at the Georgia World Congress Center in Atlanta, GA. The Company will showcase the Magellan 6Fr Robotic Catheter being used by Interventional Radiologists in embolization procedures, and will conduct Magellan Robotic System demonstrations at exhibit booth #1153.
HNSN: 1.05 (+0.02)
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study
Marketwired - Thu Feb 05, 8:01AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced FDA approval of an expanded protocol for the ARTISAN-AF IDE Study. The amended protocol now includes the use of the Thermocool(R) SmartTouch(R) Catheter (BioSense Webster, Diamond Bar, CA) and the EnSite Velocity Cardiac Mapping System (St. Jude Medical, St. Paul, MN). These technologies are used in conjunction with the Sensei(R) Robotic System to complete ablation procedures for the treatment of paroxysmal atrial fibrillation per the IDE study protocol.
HNSN: 1.05 (+0.02), STJ: 67.48 (+0.65)
Study Finds Magellan(TM) Robotic System From Hansen Medical Reduces Radiation to Operator by Over 80% in Transarterial Chemoembolization (TACE) Procedures
Marketwired - Tue Feb 03, 10:41PM CST
Hansen Medical, Inc. (NASDAQ: HNSN) -- An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting (February 28 - March 5, 2015, Atlanta, GA), found the use of the Magellan(TM) Robotic System in transarterial chemoembolization (TACE) procedures is feasible, and that remote robotic catheter navigation with Magellan leads to over 80% reduction in radiation dose to the operating physician when compared with a bedside control. Lead investigator Dr. Sandeep Rao, MD, MBA authored the abstract, which reviewed the results of seven patients treated with robot-assisted TACE using the Magellan 6Fr Robotic Catheter over a 5 month period at Sierra Medical Center in El Paso, Texas.
HNSN: 1.05 (+0.02)
IDEXX Tops Q4 Earnings, Lags Revenues; Tweaks 2015 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:25AM CST
IDEXX Laboratories, Inc. (IDXX), reported adjusted earnings per share (EPS) of 95 cents in the fourth quarter of 2014.
HNSN: 1.05 (+0.02), EW: 134.23 (+1.89), IDXX: 159.08 (+1.72), HOLX: 30.46 (+0.21)
Can the Rally in Hansen Medical (HNSN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 9:03AM CST
Can the Rally in Hansen Medical (HNSN) Shares Continue?
HNSN: 1.05 (+0.02)
Hansen Medical to Showcase Magellan(TM) Robotic System at 2015 International Aortic Summit (IAS)
Marketwired - Thu Jan 29, 8:02AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the International Aortic Summit (IAS) from February 11-13 at the Hyatt Regency in Palm Beach, AW. The Company will showcase its Magellan Robotic Catheters and will conduct Magellan Robotic System demonstrations at exhibit booth #11.
HNSN: 1.05 (+0.02)
Hansen up on first Magellan surgery in Australia
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 11:56AM CST
HNSN: 1.05 (+0.02)
Hansen Medical Announces Completion of First Clinical Procedure With the Magellan(TM) Robotic System in Australia
Marketwired - Tue Jan 27, 6:30PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first clinical procedure with the Magellan(TM) Robotic System in Australia. Interventional radiologists Dr. Gerard Goh and Dr. Jim Koukounaras, assisted by Professor Ken Thomson, performed the procedure at The Alfred Hospital in Melbourne, Australia. The Magellan Robotic System was installed in January 2015 in collaboration with Medtel Pty Limited, Hansen Medical's exclusive distribution partner in Australia and New Zealand.
HNSN: 1.05 (+0.02)
3 Health Care Stocks Under $10 to Watch: MannKind and More
at The Street - Tue Jan 27, 12:05PM CST
Keep an eye on these under-$10 health care stocks making big moves to the upside.
HNSN: 1.05 (+0.02), GERN: 3.03 (unch), MNKD: 7.00 (+0.02)
Hansen Medical to Showcase New Magellan(TM) 6Fr Robotic Catheter at 27th Annual ISET Meeting
Marketwired - Tue Jan 20, 4:30PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 27th Annual International Symposium on Endovascular Therapy (ISET) January 31-February 4 at the Diplomat Hotel in Hollywood, FL. The Company will showcase the new Magellan 6Fr Robotic Catheter and will conduct Magellan Robotic System demonstrations at exhibit booth #305.
HNSN: 1.05 (+0.02)
Is Myriad Genetics (MYGN) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 12:00PM CST
On Jan 14, 2015, Zacks Investment Research upgraded Myriad Genetics Inc. (MYGN) to a Zacks Rank #2 (Buy).
ABMD: 60.39 (+0.46), MYGN: 34.03 (+0.40), HNSN: 1.05 (+0.02), EW: 134.23 (+1.89)
Cyberonics (CYBX) Now a Buy: Are You Considering? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 3:35PM CST
On Jan 14, 2015, Zacks Investment Research upgraded Cyberonics Inc. (CYBX).
ABMD: 60.39 (+0.46), HNSN: 1.05 (+0.02), EW: 134.23 (+1.89), CYBX: 57.03 (+0.26)
IDEXX CAG, Global Growth Solid; Catalyst One in Focus in '15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 12:20PM CST
On Jan 7, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
HNSN: 1.05 (+0.02), EW: 134.23 (+1.89), IDXX: 159.08 (+1.72), ANGO: 18.78 (+0.18)
Global Medical Robotics Market 2014-2020: Orthopedic, Neurology, Laparoscopy - Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Wed Jan 07, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/clshb9/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. Key Topics Covered: 1. Executive Summary 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/cl...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Hot Stock: Hansen Medical, Shares Drop 5.2% (HNSN)
Comtex SmarTrend(R) - Wed Dec 24, 10:34AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing penny stocks, down 5.2% to $0.54 on 1.1x average daily volume. Thus far today, Hansen Medical has traded 383,000 shares, vs. average volume of 351,000 shares per day. The stock has underperformed the Dow (-5.2% to the Dow's 0.3%) and underperformed the S&P 500 (-5.2% to the S&P's 0.2%) during today's trading.
HNSN: 1.05 (+0.02)
Hot Stock: Hansen Medical, Shares Gain 6.6% (HNSN)
Comtex SmarTrend(R) - Fri Dec 19, 10:09AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing penny stocks, up 6.6% to $0.63 on 2.7x average daily volume. Thus far today, Hansen Medical has traded 749,000 shares, vs. average volume of 279,000 shares per day. The stock has outperformed the Dow (5.9% to the Dow's 0.2%) and outperformed the S&P 500 (5.9% to the S&P's 0.3%) during today's trading.
HNSN: 1.05 (+0.02)
Hansen Medical Announces Key Developments in Global Expansion Strategy
Marketwired - Fri Dec 19, 7:55AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced key recent developments in the company's global expansion strategy. Hansen and AB Medica s.p.a today announced an exclusive distribution agreement for Magellan(TM) and Sensei(R) Robotic Systems in Italy. In addition, the company's exclusive distribution partner in Kingdom of Saudi Arabia and United Arab Emirates, AFYA Medical Group, completed the first end user hospital installation of a Magellan system in the Middle East, at King Fahd Hospital in Jeddah, Saudi Arabia, in October.
HNSN: 1.05 (+0.02)
Global Medical Robotics Market 2014-2020: Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Fri Dec 12, 2:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/vg63ft/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. This technology, however, is limited to economies that are invested in medical care to a great extent. For instance, the possibility of investment into robotic arms to enhance surgical procedure in public hospitals in a developing country such as Ghana is unlikely but the developed economies of North America and Europe are the most lucrative markets for medical robotics as they have significantly invested in healthcare. However; Asian countries such as India and China are the markets of the future as the governments of these coutries are putting in efforts to improve healthcare and the economies will show a significant growth. Key Topics Covered: 1. Executive summery 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/vg...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Stock to Watch: Hansen Medical Down 6.5% (HNSN)
Comtex SmarTrend(R) - Thu Dec 04, 12:40PM CST
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing penny stocks, down 6.5% to $0.69 on 1.6x average daily volume. Thus far today, Hansen Medical has traded 349,000 shares, vs. average volume of 217,000 shares per day. The stock has underperformed the Dow (-6.2% to the Dow's 0.0%) and underperformed the S&P 500 (-6.2% to the S&P's 0.0%) during today's trading.
HNSN: 1.05 (+0.02)
